Early Detection,
​​​​​​​Made Simple

A simple, private, FDA-Approved at-home alternative to colonoscopy for cancer screening*

Regular screening from age 45 is recommended to help find colon cancer. Get started the easy way.

*For people at average risk of colon cancer who are unwilling or unable to complete a colonoscopy. A follow-up colonoscopy is recommended if the screening test is positive.

Why choose ColoSense for colon cancer screening?

ColoSense is simple, private, and clinically validated for accuracy. With FDA-approved RNA science and a collection process designed for comfort, ColoSense helps you screen confidently from your home with no prep, no dietary changes, and no time off work.

37% of people who are eligible for colon cancer screening have not completed any screening test¹.

FDA-approved and clinically validated to detect signs of colon cancer.

No messy manipulation and handling of the stool sample required.

See If It's Right for You

Frequently Asked Questions

What is ColoSense?
ColoSense is a simple stool test that screens for colon cancer. It looks for RNA markers associated with colon cancer and for hidden signs of blood in a stool sample, offering a non-invasive screening option for people who are unwilling or unable to complete a colonoscopy.
Who should take this test?
This test is for adults 45 and older who are at average risk for colon cancer and want a more convenient way to get screened. See if you qualify.
Is this test safe?
Yes. ColoSense only requires a stool sample.
Do I have to handle and separate my stool?
No, unlike other at-home stool-based tests, ColoSense has no probe component, so no messy manipulation or handling of the stool sample is required.
How much does it cost, and can I use insurance?
Most insured patients pay $0 out of pocket for screening. The only requirement is that a healthcare professional must order your test for you. We offer a $6 telehealth review completed online by our healthcare professionals, no office visit required.
How does it compare to other screening options?
ColoSense is the only test to use advanced RNA science. It's FDA-approved and clinically validated to detect signs of colon cancer. ColoSense is simple, accurate, and private. There's no prep, no dietary changes, and no time off work required. Unlike other at-home, stool-based colon cancer screening tests, ColoSense does not require a probing/scraping step, so there is no need for messy and unpleasant handling of the stool sample.
What happens after I take the survey?
You'll find out if you qualify! If you do, you will be taken to our secure patient portal to complete your order and pay your $6 telemedicine fee. No office visit required. See if you qualify.
How accurate is the test?
ColoSense is FDA-approved and clinically validated to detect signs of colon cancer. The ColoSense test showed 100% sensitivity for Stage I cancer (n = 12, average risk).4

Performance was assessed in a clinical study of 7,763 average risk patients. In this study, ColoSense demonstrated:

- 93% sensitivity for detection of colon cancer

- 88% specificity for no lesions on colonoscopy

- 45% sensitivity for detection of advanced adenomas

Additional information can be found on the FDA website: FDA Premarket Approval
See If It's Right for You

Frequently Asked Questions

What is ColoSense?
Who should take this test?
Is this test safe?
Do I have to handle and separate my stool?
How much does it cost, and can I use insurance?
How does it compare to other screening options?
What happens after I take the survey?
How accurate is the test?

Take the Survey

REFERENCES

1. American Cancer Society. Colorectal Cancer Facts & Figures 2020-2022. Atlanta, American Cancer Society; 2020.

2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.

3. American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025. Atlanta: American Cancer Society; 2023.

​​​​​​​4. Barnell EK, Wurtzler EM, La Rocca J, et al. Multitarget Stool RNA Test for Colorectal Cancer Screening. JAMA. 2023;330(18):1760–1768.

Privacy Policy
‍All trademarks, registered or otherwise, are the property of their respective owner(s).
© 2026 Geneoscopy, Inc. All rights reserved.
MKT-TD-0025v1

Early Detection,
​​​​​​​Made Simple

A simple, private, FDA-Approved at-home alternative to colonoscopy for cancer screening*

Regular screening from age 45 is recommended to help find colon cancer early. Get started the easy way.

See If It's Right for You
*For people at average risk of colon cancer who are unwilling or unable to complete a colonoscopy. A follow-up colonoscopy is recommended if the screening test is positive.
OUR PROCESS

How It Works

We keep it simple.

  1. 1. Take Our Survey and See If You Qualify

    ColoSense is intended for patients 45 years of age or older that are due for a colon cancer screening and NOT at high risk of colon cancer.

  2. 2. Place Your Order Online

    If you qualify, you can easily order your ColoSense test through our secure patient portal. You’ll provide your insurance information so our agents can confirm your coverage, and enter your shipping address. Because ColoSense requires a healthcare professional’s order, we offer a simple $6 telehealth review (no office visit or co-pay required) and our healthcare professionals will review your information and place the order for you.

  3. 3. Receive Your ColoSense Kit

    We'll send you everything you need to comfortably, easily, and privately provide a stool sample. No extra thought or materials required.

  4. 4. Send in Your Sample

    We'll provide a prepaid FedEx shipping label in the kit so you can take the sample to your nearest FedEx or FedEx drop location and be on your way.

  5. 5. Receive Your Result

    You'll receive your result in approximately 2 weeks. A healthcare professional will be able to discuss your result and help with next steps if a positive result is received.
    See If It's Right for You

Why choose ColoSense for colon cancer screening?

ColoSense is simple, private, and clinically validated for accuracy. With FDA-approved RNA science and a collection process designed for comfort, ColoSense helps you screen confidently from your home with no prep, no dietary changes, and no time off work.

37% of people who are eligible for colon cancer screening have not completed any screening test¹.

FDA-approved and clinically validated to detect signs of colon cancer.

No messy manipulation and handling of the stool sample required.

See If It's Right for You

Frequently Asked Questions

What is ColoSense?
ColoSense is a simple stool test that screens for colon cancer. It looks for RNA markers associated with colon cancer and for hidden signs of blood in a stool sample, offering a non-invasive screening option for people who are unwilling or unable to complete a colonoscopy.
Who should take this test?
This test is for adults 45 and older who are at average risk for colon cancer and want a more convenient way to get screened. See if you qualify.
Is this test safe?
Yes. ColoSense only requires a stool sample.
Do I have to handle and separate my stool?
No, unlike other at-home stool-based tests, ColoSense has no probe component, so no messy manipulation or handling of the stool sample is required.
How much does it cost, and can I use insurance?
Most insured patients pay $0 out of pocket for screening. The only requirement is that a healthcare professional must order your test for you. We offer a $6 telehealth review completed online by our healthcare professionals, no office visit required.
How does it compare to other screening options?
ColoSense is the only test to use advanced RNA science. It's FDA-approved and clinically validated to detect signs of colon cancer. ColoSense is simple, accurate, and private. There's no prep, no dietary changes, and no time off work required. Unlike other at-home, stool-based colon cancer screening tests, ColoSense does not require a probing/scraping step, so there is no need for messy and unpleasant handling of the stool sample.
What happens after I take the survey?
You'll find out if you qualify! If you do, you will be taken to our secure patient portal to complete your order and pay your $6 telemedicine fee. No office visit required. See if you qualify.
How accurate is the test?
ColoSense is FDA-approved and clinically validated to detect signs of colon cancer. The ColoSense test showed 100% sensitivity for Stage I cancer (n = 12, average risk).4

Performance was assessed in a clinical study of 7,763 average risk patients. In this study, ColoSense demonstrated:

- 93% sensitivity for detection of colon cancer

- 88% specificity for no lesions on colonoscopy

- 45% sensitivity for detection of advanced adenomas

Additional information can be found on the FDA website: FDA Premarket Approval
See If It's Right for You

Take the Survey

REFERENCES

1. American Cancer Society. Colorectal Cancer Facts & Figures 2020-2022. Atlanta, American Cancer Society; 2020.

2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.

3. American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025. Atlanta: American Cancer Society; 2023.

​​​​​​​4. Barnell EK, Wurtzler EM, La Rocca J, et al. Multitarget Stool RNA Test for Colorectal Cancer Screening. JAMA. 2023;330(18):1760–1768.

Privacy Policy
‍All trademarks, registered or otherwise, are the property of their respective owner(s).
© 2025 Geneoscopy, Inc. All rights reserved.
MKT-TD-0025v2

Early Detection,
​​​​​​​Made Simple

A simple, private, FDA-Approved at-home alternative to colonoscopy for cancer screening*

Regular screening from age 45 is recommended to help find colon cancer early. Get started the easy way.

See If It's Right for You
*For people at average risk of colon cancer who are unwilling or unable to complete a colonoscopy. A follow-up colonoscopy is recommended if the screening test is positive.
OUR PROCESS

How It Works

We keep it simple

1. Take Our Survey and See If You Qualify

ColoSense is intended for patients 45 years of age or older that are due for a colon cancer screening and NOT at high risk of colon cancer.

2. Place Your Order Online

If you qualify, you can easily order your ColoSense test through our secure patient portal. You’ll provide your insurance information so our agents can confirm your coverage, and enter your shipping address. Because ColoSense requires a healthcare professional’s order, we offer a simple $6 telehealth review (no office visit or co-pay required) and our healthcare professionals will review your information and place the order for you.

3. Receive Your ColoSense Kit

We'll send you everything you need to comfortably, easily, and privately provide a stool sample. No extra thought or materials required.

4. Send in Your Sample

We'll provide a prepaid FedEx shipping label in the kit so you can take the sample to your nearest FedEx or FedEx drop location and be on your way.

5. Receive Your Result

You'll receive your result in approximately 2 weeks. A healthcare professional will be able to discuss your result and help with next steps if the test indicates you may need further testing.

3. Receive Your ColoSense Kit

We'll send you everything you need to comfortably, easily, and privately provide a stool sample. No extra thought or materials required.

1. Take Our Survey and See If You Qualify

ColoSense is intended for patients 45 years of age or older that are due for a colon cancer screening and NOT at high risk of colon cancer.

5. Receive Your Result

You'll receive your result in approximately 2 weeks. A healthcare professional will be able to discuss your result and help with next steps if the test indicates you may need further testing.

See If It's Right for You

Take the Survey

Why choose ColoSense for colon cancer screening?

ColoSense is simple, private, and clinically validated for accuracy. With FDA-approved RNA science and a collection process designed for comfort, ColoSense helps you screen confidently from your home with no prep, no dietary changes, and no time off work.

37% of people who are eligible for colon cancer screening have not completed any screening test¹.

FDA-approved and clinically validated to detect signs of colon cancer early.

No messy manipulation and handling of the stool sample required.

See If It's Right for You

Frequently Asked Questions

What is ColoSense?
ColoSense is a simple stool test that screens for colon cancer cancer. It looks for RNA markers associated with colon cancer and for hidden signs of blood in a stool sample, offering a non-invasive screening option for people who are unwilling or unable to complete a colonoscopy.
Who should take this test?
This test is for adults 45 and older who are at average risk for colon cancer and want a more convenient way to get screened. See if you qualify.
Is this test safe?
Yes. ColoSense only requires a stool sample.
Do I have to handle and separate my stool?
No, unlike other at-home stool-based tests, ColoSense has no probe component, so no messy manipulation or handling of the stool sample is required.
How much does it cost, and can I use insurance?
Most insured patients pay $0 out of pocket for screening. The only requirement is that a healthcare professional must order your test for you. We offer a $6 telehealth review completed online by our healthcare professionals, no office visit required.
How does it compare to other screening options?
ColoSense is the only test to use advanced RNA science. It's FDA-approved and clinically validated to detect signs of colon cancer early. ColoSense is simple, accurate, and private. There's no prep, no dietary changes, and no time off work required. Unlike other at-home, stool-based colon cancer screening tests, ColoSense does not require a probing/scraping step, so there is no need for messy and unpleasant handling of the stool sample.
What happens after I take the survey?
You'll find out if you qualify! If you do, you will be taken to our secure patient portal to complete your order and pay your $6 telemedicine fee. No office visit required. See if you qualify.
How accurate is the test?
ColoSense is FDA-approved and clinically validated to detect signs of colon cancer early. The ColoSense test showed 100% sensitivity for Stage I cancer (n = 12, average risk).4

Performance was assessed in a clinical study of 7,763 average risk patients. In this study, ColoSense demonstrated:

- 93% sensitivity for detection of colon cancer

- 88% specificity for no lesions on colonoscopy

- 45% sensitivity for detection of advanced adenomas

Additional information can be found on the FDA website: FDA Premarket Approval
See If It's Right for You
Privacy policy
All trademarks, registered or otherwise, are the property of their respective owner(s).
© 2025 83bar. All Rights Reserved.
MKT-TD-0025v3